Published in Exp Neurol on March 04, 2008
Inducible protein-10, a potential driver of neurally controlled interleukin-10 and morbidity in human blunt trauma. Crit Care Med (2014) 1.57
B cells and autoantibodies: complex roles in CNS injury. Trends Immunol (2010) 1.05
Oxidative burst of circulating neutrophils following traumatic brain injury in human. PLoS One (2013) 0.95
A center's experience: pulmonary function in spinal cord injury. Lung (2014) 0.89
Nociceptors as chronic drivers of pain and hyperreflexia after spinal cord injury: an adaptive-maladaptive hyperfunctional state hypothesis. Front Physiol (2012) 0.88
CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury. Exp Neurol (2011) 0.88
Resveratrol attenuates spinal cord injury-induced inflammatory damage in rat lungs. Int J Clin Exp Pathol (2015) 0.87
The systemic inflammatory response after spinal cord injury in the rat is decreased by α4β1 integrin blockade. J Neurotrauma (2012) 0.85
Ex vivo diffusion tensor imaging of spinal cord injury in rats of varying degrees of severity. J Neurotrauma (2013) 0.85
Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum Biomarkers. J Neurotrauma (2015) 0.84
Spinal cord injury causes chronic liver pathology in rats. J Neurotrauma (2014) 0.83
Human spinal cord injury causes specific increases in surface expression of β integrins on leukocytes. J Neurotrauma (2011) 0.82
Neuroprotective effects of alpha-lipoic acid in experimental spinal cord injury in rats. J Spinal Cord Med (2010) 0.81
Spinal cord injury causes sustained disruption of the blood-testis barrier in the rat. PLoS One (2011) 0.81
Monocyte locomotion inhibitory factor produced by E. histolytica improves motor recovery and develops neuroprotection after traumatic injury to the spinal cord. Biomed Res Int (2013) 0.78
The Transcriptional Response of Neurotrophins and Their Tyrosine Kinase Receptors in Lumbar Sensorimotor Circuits to Spinal Cord Contusion is Affected by Injury Severity and Survival Time. Front Physiol (2013) 0.78
CD11d integrin blockade reduces the systemic inflammatory response syndrome after traumatic brain injury in rats. Exp Neurol (2015) 0.78
Protective effects of Vitamin C against spinal cord injury-induced renal damage through suppression of NF-κB and proinflammatory cytokines. Neurol Sci (2014) 0.77
The effect of spinal cord injury on the neurochemical properties of vagal sensory neurons. Am J Physiol Regul Integr Comp Physiol (2015) 0.77
Gut dysbiosis impairs recovery after spinal cord injury. J Exp Med (2016) 0.77
Changes in Gene Expression and Metabolism in the Testes of the Rat following Spinal Cord Injury. J Neurotrauma (2016) 0.76
Gastric vagal motoneuron function is maintained following experimental spinal cord injury. Neurogastroenterol Motil (2014) 0.76
Suprapubic bladder catheterization of male spinal-cord-injured Sprague-Dawley rats. J Am Assoc Lab Anim Sci (2012) 0.75
Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation (2016) 0.75
Spinal cord injury modulates the lung inflammatory response in mechanically ventilated rats: a comparative animal study. Physiol Rep (2016) 0.75
The cellular inflammatory response in human spinal cords after injury. Brain (2006) 3.01
Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci (2004) 1.80
A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma (2010) 1.54
A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma (2010) 1.13
Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem (2004) 1.11
Chronic pain after clip-compression injury of the rat spinal cord. Exp Neurol (2002) 1.10
A systematic review of directly applied biologic therapies for acute spinal cord injury. J Neurotrauma (2010) 1.10
The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain (2004) 1.08
Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats. Brain Res (2008) 1.02
Neutralizing intraspinal nerve growth factor with a trkA-IgG fusion protein blocks the development of autonomic dysreflexia in a clip-compression model of spinal cord injury. J Neurotrauma (2002) 1.01
Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord. J Neurosci (2005) 1.00
NGF message and protein distribution in the injured rat spinal cord. Exp Neurol (2004) 0.97
Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J Neurochem (2005) 0.95
Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function. Exp Neurol (2008) 0.95
Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. J Neurotrauma (2005) 0.94
Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury. Exp Neurol (2008) 0.94
The dark side of neuroplasticity. Exp Neurol (2011) 0.93
Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat. J Neurosci Res (2007) 0.93
An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats. J Neurochem (2004) 0.93
A CD11d monoclonal antibody treatment reduces tissue injury and improves neurological outcome after fluid percussion brain injury in rats. J Neurotrauma (2012) 0.92
An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury. Exp Neurol (2008) 0.91
Treatment with an anti-CD11d integrin antibody reduces neuroinflammation and improves outcome in a rat model of repeated concussion. J Neuroinflammation (2013) 0.91
Differential detection and distribution of microglial and hematogenous macrophage populations in the injured spinal cord of lys-EGFP-ki transgenic mice. J Neuropathol Exp Neurol (2012) 0.90
Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy. J Neurosurg Spine (2009) 0.90
NGF mRNA is expressed in the dorsal root ganglia after spinal cord injury in the rat. Exp Neurol (2007) 0.89
Debate: "is increasing neuroinflammation beneficial for neural repair?". J Neuroimmune Pharmacol (2006) 0.89
CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury. Exp Neurol (2011) 0.88
A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes, and tissue damage after spinal cord injury. J Neurotrauma (2011) 0.86
What causes autonomic dysreflexia after spinal cord injury? Clin Auton Res (2002) 0.85
The systemic inflammatory response after spinal cord injury in the rat is decreased by α4β1 integrin blockade. J Neurotrauma (2012) 0.85
Blockade of the 5-HT3 receptor for days causes sustained relief from mechanical allodynia following spinal cord injury. J Neurosci Res (2009) 0.85
Autonomic dysreflexia, induced by noxious or innocuous stimulation, does not depend on changes in dorsal horn substance p. J Neurotrauma (2004) 0.85
A therapeutic time window for anti-CD 11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury. J Neurosurg Spine (2006) 0.84
Cellular imaging of inflammation after experimental spinal cord injury. Mol Imaging (2005) 0.84
Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the Lys-Egfp-ki mouse model. J Neuroimmunol (2013) 0.83
Human spinal cord injury causes specific increases in surface expression of β integrins on leukocytes. J Neurotrauma (2011) 0.82
Effects of spinal cord injury on synaptic inputs to sympathetic preganglionic neurons. Prog Brain Res (2006) 0.82
Comparison of effects of methylprednisolone and anti-CD11d antibody treatments on autonomic dysreflexia after spinal cord injury. Exp Neurol (2005) 0.81
Anti-alpha4beta1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes. Inflamm Res (2010) 0.80
The N-methyl-D-aspartate receptor splice variant NR1-4 C-terminal domain. Deletion analysis and role in subcellular distribution. J Biol Chem (2001) 0.79
Effects of a novel tripeptide on neurological outcomes after spinal cord injury. Neuroreport (2006) 0.78
Magnetic resonance imaging versus histological assessment for estimation of lesion volume after experimental spinal cord injury. Laboratory investigation. J Neurosurg Spine (2008) 0.78